Nano-X Imaging Ltd.: Business Overview, Financials & Competitive Analysis
Nano-X Imaging Ltd. scores 4/10 on the AskCyborg Cyborg Score (Mixed). Nano-X is a pre-profitability growth-stage company betting on AI-driven medical imaging with strategic partnerships, but faces significant operational and execution risks. The company has experienced revenue growth of 92.3% over the past three years, indicating strong upward trajectory. However, profitability metrics are concerning, with an operating margin of -485.4%.
What is Nano-X Imaging Ltd.'s industry? Nano-X Imaging Ltd. (nanox.vision) operates in Medical Devices & Diagnostics / Digital Health Imaging. AskCyborg classifies Nano-X Imaging Ltd. under Medical Devices & Diagnostics / Digital Health Imaging in its company registry.
Nano-X Imaging develops a commercial-grade tomographic imaging device with a digital X-ray source, provides teleradiology services, and develops artificial intelligence applications for real-world medical imaging. The...
Cyborg Score thesis
Nano-X is a pre-profitability growth-stage company betting on AI-driven medical imaging with strategic partnerships, but faces...
Read the full analyst-debate transcript →Get the Latest Nano-X Imaging Ltd. Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeNano-X Imaging Ltd. Overview
Pro stress-test →Nano-X Imaging develops a commercial-grade tomographic imaging device with a digital X-ray source, provides teleradiology services, and develops artificial intelligence applications for real-world medical imaging. The company has developed a digital X-ray source enabling cost reduction of imaging systems by orders of magnitude and plans mass deployment of systems to drive early detection preventive healthcare.
Strategic Profile
Pro stress-test →The company offers Nanox.MARKETPLACE connecting imaging facilities with radiologists, Nanox.CONNECT for regulatory approvals, and AI-based imaging solutions designed to identify or predict undiagnosed medical conditions. Nano-X's collaboration with 3DR Labs integrates its FDA-cleared AI tools into a portfolio reaching over 1,800 U.S. hospitals, representing a pivotal step in scaling AI imaging solutions.
Competitive Landscape
Pro stress-test →Nano-X operates in the healthcare sector, focusing on innovative medical imaging solutions. The company competes in medical devices with traditional imaging manufacturers and emerging AI-driven diagnostics platforms. Competitive advantages center on proprietary digital X-ray source technology and growing AI capabilities, though the company remains smaller than established competitors like Siemens, GE Healthcare, and Philips.
Industry Context
Nano-X Imaging Ltd. operates in Medical Devices & Diagnostics / Digital Health Imaging.
Key facts
Founded: 2011 · Headquarters: Petah Tikva, Israel · Employees: 165 · Revenue: $12.3M · Market cap: $237M